
    
      This is a randomized blinded multicenter controlled study on 64 subjects (18 years or older)
      with the diagnosis of unilateral arthralgia of the TMJ.

      The subject visit the clinic at three occasions; one enrollment visit, one baseline treatment
      visit and one evaluation visit one month after baseline.

      One week after baseline a follow-up telephone call is made with the purpose to track adverse
      events.

      Pain questionaries are completed morning, lunch and dinnertime during three days before
      treatment, five days after treatment and three days proceeding the evaluation visit.

      The study Ã­s planned to commence 10th December 2013 and last patient out 15th January 2015.
    
  